Quantifying the evidence for the risk of metabolic syndrome and its components following androgen deprivation therapy for prostate cancer: a meta-analysis

HIGHLIGHTS

• who: Cecilia Bosco and colleagues from the AUSTRIA have published the article: Quantifying the Evidence for the Risk of Metabolic Syndrome and Its Components following Androgen Deprivation Therapy for Prostate Cancer: A Meta-Analysis, in the Journal: PLOS ONE | DOI:10.1371/journal.pone [0117344]. March 20, 2015 of December/23,/2014
• what: The latter would require studies focused on specific subtypes of ADT, but most studies to date did not show results for different subtypes of ADT.
• how: Nine studies were selected for primary data-analysis from which six studies were conducted . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.